Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911 · see citing works

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., de Faire, U., Dahlén, G. H., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474 · see citing works

Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

Mancini, G. B. J., Henry, G. C., Macaya, C., O’Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H. G., Lüscher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,056 · see citing works

Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.

Doucette, J. W., Corl, P. D., Payne, H. M., Flynn, A. E., Goto, M., Nassí, M., & Segal, J. (1992) · Circulation · doi:10.1161/01.cir.85.5.1899 · Cited by 1,017 · see citing works

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H. G., Rousseau, M. F., Salem, D. N., Kostis, J. B., Benedict, C. R., Bourassa, M. G., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 665 · see citing works

High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor

Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602 · see citing works

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Ridker, P. M., Vaughan, D. E., Manson, J., Hennekens, C. H., & Stampfer, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90998-v · Cited by 580 · see citing works

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.

Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400 · see citing works

Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking

Newby, D. E., Wright, R. A., Labinjoh, C., Ludlam, C. A., Fox, K. A. A., Boon, N. A., & Webb, D. J. (1999) · Circulation · doi:10.1161/01.cir.99.11.1411 · Cited by 379 · see citing works

Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study

Gebara, O., Mittleman, M. A., Sutherland, P. A., Lipinska, I., Matheney, T. H., Xu, P., Welty, F. K., Wilson, P. W. F., Levy, D. A., Muller, J. E., et al. (1995) · Circulation · doi:10.1161/01.cir.91.7.1952 · Cited by 298 · see citing works

Effects of Ramipril on Plasma Fibrinolytic Balance in Patients With Acute Anterior Myocardial Infarction

Vaughan, D. E., Rouleau, J. L., Ridker, P. M., Arnold, J. M. O., Menapace, F. J., & Pfeffer, M. A. (1997) · Circulation · doi:10.1161/01.cir.96.2.442 · Cited by 264 · see citing works

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.

Jansson, J.-H., Olofsson, B. O., & Nilsson, T. (1993) · Circulation · doi:10.1161/01.cir.88.5.2030 · Cited by 241 · see citing works

Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.

Nakashima, M., Mombouli, J., Taylor, A. A., & Vanhoutte, P. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116907 · Cited by 230 · see citing works

Coronary flow velocity dynamics in normal and diseased arteries

Ofili, E., Labovitz, A. J., & Kern, M. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90128-y · Cited by 200 · see citing works

An Endothelial Storage Granule for Tissue-Type Plasminogen Activator

EMEIS, J. J., Schrauwen, Y., van den Hoogen, C. M., de Priester, W., Westmuckett, A. D., & Lupu, F. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.245 · Cited by 158 · see citing works

Bradykinin Stimulates Tissue Plasminogen Activator Release in Human Vasculature

Brown, N. J., Gainer, J. V., Stein, C., & Vaughan, D. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1431 · Cited by 152 · see citing works

Selective Stimulation of Tissue-Type Plasminogen Activator (t-PA) In Vivo by Infusion of Bradykinin

Brown, N. J., Nadeau, J., & Vaughan, D. E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656000 · Cited by 145 · see citing works

Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction

Wright, R. A., Flapan, A. D., Alberti, K. G. M. M., Ludlam, C. A., & Fox, K. A. A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90543-6 · Cited by 139 · see citing works

Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool

Schrauwen, Y., Kooistra, T., de Vries, R., & Emeis, J. J. (1995) · Blood · doi:10.1182/blood.v85.12.3510.bloodjournal85123510 · Cited by 135 · see citing works

Increased Expression of Tissue Plasminogen Activator and Its Inhibitor and Reduced Fibrinolytic Potential of Human Endothelial Cells Cultured in Elevated Glucose

Maiello, M., Boeri, D., Podestà, F., Cagliero, E., Vichi, M., Odetti, P. R., Adezati, L., & Lorenzi, M. (1992) · Diabetes · doi:10.2337/diab.41.8.1009 · Cited by 93 · see citing works

Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells

Kawai, Y., Matsumoto, Y., Watanabe, K., Yamamoto, H., Satoh, K., Murata, M., Handa, M., & Ikeda, Y. (1996) · Blood · doi:10.1182/blood.v87.6.2314.bloodjournal8762314 · Cited by 89 · see citing works

Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature

Stein, C. M., Brown, N. L., Vaughan, D. E., Lang, C. C., & Wood, A. J. J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00210-1 · Cited by 85 · see citing works

Bradykinin-Induced Vasodilation of Human Coronary Arteries In Vivo: Role of Nitric Oxide and Angiotensin-Converting Enzyme

Kuga, T., Mohri, M., Egashira, K., Hirakawa, Y., Tagawa, T., Shimokawa, H., & Takeshita, A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00112-5 · Cited by 83 · see citing works

Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture

Pandolfi, A., Iacoviello, L., Capani, F., Vitacolonna, E., Donati, M. B., & Consoli, A. (1996) · Diabetologia · doi:10.1007/s001250050594 · Cited by 76 · see citing works

Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition

Prasad, A., Husain, S., & Quyyumi, A. A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00611-1 · Cited by 63 · see citing works

Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries

Toda, N., & Okamura, T. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.3.h988 · Cited by 62 · see citing works

Beneficial Effects of Bradykinin on Myocardial Energy Metabolism and Infarct Size

Linz, W., Wiemer, G., & Schölkens, B. A. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00466-9 · Cited by 58 · see citing works

Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man

Labinjoh, C. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00126-7 · Cited by 41 · see citing works

Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease

Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J. M., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Circulation · doi:10.1161/circulationaha.107.183885 · Cited by 752 · see citing works

Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis

Henry, B. M., Vikse, J., Benoit, S. W., Favaloro, E. J., & Lippi, G. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.027 · Cited by 381 · see citing works

Treatment of Hypertension in Patients With Coronary Artery Disease

Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000207 · Cited by 260 · see citing works

Treatment of Hypertension in Patients With Coronary Artery Disease

Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Hypertension · doi:10.1161/hyp.0000000000000018 · Cited by 175 · see citing works

Methods for Evaluating Endothelial Function in Humans

Barac, A., Campia, U., & Panza, J. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000259601.38807.a6 · Cited by 142 · see citing works

The Vasculature in Prediabetes

Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137 · see citing works

Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans

Oliver, J. J., Webb, D. J., & Newby, D. E. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000189309.05924.88 · Cited by 137 · see citing works

Treatment of Hypertension in Patients With Coronary Artery Disease

Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.038 · Cited by 133 · see citing works

Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin

Pretorius, M., Rosenbaum, D., Vaughan, D. E., & Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000046268.59922.a4 · Cited by 96 · see citing works

Provision of cardiovascular protection by ACE inhibitors:a review of recent trials

Bertrand, M. E. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x4185 · Cited by 88 · see citing works

Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans

Smith, D. T., Hoetzer, G. L., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.027870 · Cited by 77 · see citing works

Impact of kinins in the treatment of cardiovascular diseases

Regoli, D. C., Plante, G. E., & Gobeil, F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.04.002 · Cited by 77 · see citing works

Treatment of hypertension in patients with coronary artery disease

Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.03.002 · Cited by 79 · see citing works

Prevention of Diabetes-Induced Microangiopathy by Human Tissue Kallikrein Gene Transfer

Emanueli, C., Salis, M. B., Pinna, A., Stacca, T., Milia, A. F., Spano, A., Chao, J., Chao, L., Sciola, L., & Madeddu, P. R. (2002) · Circulation · doi:10.1161/01.cir.0000027104.33206.c8 · Cited by 76 · see citing works

The Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas receptor axis: A potential target for treating thrombotic diseases

Fraga‐Silva, R. A., Silva, D. D., Montecucco, F., Mach, F., Stergiopulos, N., da Silva, R., & Santos, R. A. S. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0396 · Cited by 66 · see citing works

Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease

Robinson, S. D., Ludlam, C. A., Boon, N. A., & Newby, D. E. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.143248 · Cited by 62 · see citing works

Regulation of local availability of active tissue‐type plasminogen activator in vivo in man

Hrafnkelsdóttir, Þ. J., Guðnason, Þ., Wall, U., Jern, C., & Jern, S. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00948.x · Cited by 62 · see citing works

Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy

Witherow, F. N., Dawson, P., Ludlam, C. A., Fox, K. A. A., & Newby, D. E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02061-2 · Cited by 52 · see citing works

Type-2 Diabetic Leprdb/db Mice Show a Defective Microvascular Phenotype under basal conditions and an Impaired Response to Angiogenesis Gene Therapy in the setting of Limb Ischemia

Emanueli, C. (2006) · Frontiers in bioscience · doi:10.2741/2205 · Cited by 43 · see citing works

Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms

Yaron, J. R., Zhang, L., Guo, Q., Haydel, S. E., & Lucas, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.648947 · Cited by 43 · see citing works

Bradykinin and Its Metabolite Bradykinin 1-5 Inhibit Thrombin-Induced Platelet Aggregation in Humans

Murphey, L. J., Malave, H. A., Petro, J., Biaggioni, I., Byrne, D. W., Vaughan, D. E., Luther, J. M., Pretorius, M., & Brown, N. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104026 · Cited by 42 · see citing works

Smoking Impairs Bradykinin-Stimulated t-PA Release

Pretorius, M., Rosenbaum, D. A., Lefèbvre, J., Vaughan, D. E., & Brown, N. J. (2002) · Hypertension · doi:10.1161/hy0302.105767 · Cited by 42 · see citing works

Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin

Matsumoto, T., Takashima, H., Ohira, N., Tarutani, Y., Yasuda, Y., Yamane, T., Matsuo, S., & Horie, M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.064 · Cited by 42 · see citing works

Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats

Bledsoe, G., Chao, L., & Chao, J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01129.2002 · Cited by 41 · see citing works

Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy

Ridderstråle, W., Ulfhammer, E., Jern, S., & Hrafnkelsdóttir, Þ. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000210540.35296.62 · Cited by 39 · see citing works

Fixed-Dose??Combination Lercanidipine/Enalapril

Hair, P. I., Scott, L. J., & Perry, C. M. (2007) · Drugs · doi:10.2165/00003495-200767010-00007 · Cited by 38 · see citing works

Role of thrombotic and fibrinolytic factors in acute coronary syndromes

Saigo, M., Hsue, P. Y., & Waters, D. D. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.02.003 · Cited by 38 · see citing works

Ethnicity Affects Vasodilation, but Not Endothelial Tissue Plasminogen Activator Release, in Response to Bradykinin

Rosenbaum, D. A., Pretorius, M., Gainer, J. V., Byrne, D. W., Murphey, L. J., Painter, C., Vaughan, D. E., & Brown, N. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000017704.45007.1d · Cited by 38 · see citing works

Tissue Kallikrein and Kinin Infusion Rescues Failing Myocardium After Myocardial Infarction

Yao, Y., Yin, H. H., Shen, B., Chao, L., & Chao, J. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.04.009 · Cited by 37 · see citing works

The Relationship Between Flow-Mediated Brachial Artery Vasodilation and Coronary Vasomotor Responses to Bradykinin: Comparison with Those to Acetylcholine

Matsuo, S., Matsumoto, T., Takashima, H., Ohira, N., Yamane, T., Yasuda, Y., Tarutani, Y., & Horie, M. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200408000-00004 · Cited by 37 · see citing works

Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients

Matsumoto, T., Minai, K., Horie, H., Ohira, N., Takashima, H., Tarutani, Y., Yasuda, Y., Ozawa, T., Matsuo, S., Kinoshita, M., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00162-1 · Cited by 37 · see citing works

Plasma Kallikrein Inhibitors in Cardiovascular Disease

Kolte, D. S., & Shariat‐Madar, Z. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000069 · Cited by 36 · see citing works

Contribution of bradykinin to the cardioprotective effects of ACE inhibitors

Murphey, L. J. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90062-9 · Cited by 32 · see citing works

The Effects of the Contact Activation System on Hemorrhage

Simão, F., & Feener, E. P. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00121 · Cited by 31 · see citing works

Tissue-type plasminogen activator release

Muldowney, J. A. S., & Vaughan, D. E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02060-0 · Cited by 29 · see citing works

Cardiac Sympathetic Nerve Stimulation Triggers Coronary t-PA Release

Björkman, J., Jern, S., & Jern, C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000072966.23250.1e · Cited by 28 · see citing works

Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

Fogari, R., Zoppi, A., Mugellini, A., Maffioli, P., Lazzari, P., & Derosa, G. (2011) · Hypertension Research · doi:10.1038/hr.2011.137 · Cited by 26 · see citing works

Hemodynamic effect of propofol in enalapril-treated hypertensive patients during induction of general anesthesia.

Malinowska-Zaprzałka, M., Wojewódzka‐Żeleźniakowicz, M., Dryl, D., Grabowska, S. Z., & Chabielska, E. (2005) · PubMed · Cited by 24 · see citing works

Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence

Borghi, C., & Francesca, S. (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s23232 · Cited by 21 · see citing works

Angiotensin-Converting Enzyme Inhibition Increases Basal Vascular Tissue Plasminogen Activator Release in Women But Not in Men

Pretorius, M., Luther, J. M., Murphey, L. J., Vaughan, D. E., & Brown, N. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186185.13977.94 · Cited by 21 · see citing works

Quinapril

Culy, C. R., & Jarvis, B. (2002) · Drugs · doi:10.2165/00003495-200262020-00009 · Cited by 20 · see citing works

Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension

Borghi, C., & Cicero, A. F. G. (2010) · Clinical Drug Investigation · doi:10.1007/bf03256912 · Cited by 19 · see citing works

Reinforcing a Continuum of Care: In-Hospital Initiation of Long-Term Secondary Prevention Following Acute Coronary Syndromes

Rockson, S. G., deGoma, E. M., & Fonarow, G. C. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6043-1 · Cited by 18 · see citing works

REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease

Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J. M., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.183885 · Cited by 17 · see citing works

Endogenous Tissue Plasminogen Activator Enhances Fibrinolysis and Limits Thrombus Formation in a Clinical Model of Thrombosis

Lucking, A. J., Gibson, K. R., Paterson, E. E., Faratian, D., Ludlam, C. A., Boon, N. A., Fox, K. A. A., & Newby, D. E. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300395 · Cited by 16 · see citing works

Impaired myocardial t‐PA release in patients with coronary artery disease

Österlund, B., Jern, S., Jern, C., Seeman-Lodding, H., ÖSTMAN, M., Johansson, G., & Biber, B. (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2008.01741.x · Cited by 16 · see citing works

Clots, kinins and coronaries

Cruden, N. L. M., & Newby, D. E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.038 · Cited by 15 · see citing works

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Modulates Coronary Release of Tissue Plasminogen Activator in Response to Bradykinin

Ohira, N., Matsumoto, T., Tamaki, S., TAKASHIMA, H., Tarutani, Y., Yamane, T., Yasuda, Y., & Horie, M. (2004) · Hypertension Research · doi:10.1291/hypres.27.39 · Cited by 15 · see citing works

Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease

Dell’Italia, L. J., Ročić, P., & Lucchesi, P. A. (2002) · Current Problems in Cardiology · doi:10.1067/mcd.2002.121580 · Cited by 14 · see citing works

Erratum

&NA; (2011) · Clinical Drug Investigation · doi:10.2165/11533610-000000000-00000 · Cited by 13 · see citing works

Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease

Stevenson, T. K., Moore, S. J., Murphy, G. G., & Lawrence, D. A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1740265 · Cited by 12 · see citing works

Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems

Bentley, J. P., Asselbergs, F. W., Coffey, C. S., Hebert, P. R., Moore, J. H., Hillege, H. L., & van Gilst, W. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012757 · Cited by 12 · see citing works

Brachial Artery Flow-Mediated Vasodilation Is Correlated with Coronary Vasomotor and Fibrinolytic Responses Induced by Bradykinin

Tarutani, Y., Matsumoto, T., TAKASHIMA, H., Yamane, T., & Horie, M. (2005) · Hypertension Research · doi:10.1291/hypres.28.59 · Cited by 12 · see citing works

Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms

Jastrzebska, M. M., Widecka, K., Naruszewicz, M., Ciechanowicz, A., Janczak-Bazan, A., Foltyńska, A., Gorący, I., Chetstowski, K., & Wesotowska, T. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80053-x · Cited by 12 · see citing works

Invasive assessment of the coronary circulation: intravascular ultrasound and Doppler

Newby, D. E., & Fox, K. A. A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01582.x · Cited by 11 · see citing works

Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases

Saibeni, S., Spina, L., Virgilio, T., Folcioni, A., Borsi, G., de Franchis, R., Cugno, M., & Vecchi, M. L. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282efa3fc · Cited by 11 · see citing works

Blood Pressure Reduction and Tissue-Type Plasminogen Activator Release

Brown, N. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000209952.30603.e9 · Cited by 11 · see citing works

Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors

Furon, J., Yetim, M., Pouettre, E., de Lizarrondo, S. M., Maubert, E., Hommet, Y., Lebouvier, L., Zheng, Z., Ali, C., & Vivien, D. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00411-w · Cited by 10 · see citing works

Cigarette smoking impairs bradykinin-stimulated tissue plasminogen activator release in human coronary circulation

Takashima, H., Matsumoto, T., Nakae, I., Yamane, T., & Horie, M. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.024 · Cited by 8 · see citing works

Endothelial function in patients with chest pain and normal coronary angiograms.

Grąbczewska, Z., Thews, M., Góralczyk, K., & Kubica, J. (2007) · PubMed · Cited by 8 · see citing works

The Role of Renin Angiotensin System Intervention in Stage B Heart Failure

Collier, P. H., & McDonald, K. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.11.006 · Cited by 7 · see citing works

Bradykinin for the Treatment of Cardiovascular Disease

Palkhiwala, S. A., Frishman, W. H., & Warshafsky, S. (2001) · Heart Disease · doi:10.1097/00132580-200109000-00010 · Cited by 7 · see citing works

Angiotensin-Converting Enzyme Inhibition Augments Coronary Release of Tissue Plasminogen Activator in Women But Not in Men

Matsumoto, T., Takashima, H., Nakae, I., Yamane, T., Hayashi, H., & Horie, M. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.154278 · Cited by 5 · see citing works

AHA/ASH Scientific Statement Treatment of hypertension in patients with coronary artery disease A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension

Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Cited by 5 · see citing works

Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature

Blomstrand, C., Westerlind, A., & Jern, C. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-11-0693 · Cited by 5 · see citing works

Association between brachial–ankle pulse wave velocity and endothelium‐dependent and ‐independent coronary vasomotor function

Yoshino, T., Nakae, I., Matsumoto, T., Mitsunami, K., & Horie, M. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05455.x · Cited by 4 · see citing works

In vivo release of tissue-type plasminogen activator antigen from the human brachial artery

Dovjak, N., Blinc, A., & Keber, D. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00132-9 · Cited by 4 · see citing works

β-blockade abolishes the augmented cardiac tPA release induced by transactivation of heterodimerised bradykinin receptor-2 and β2-adrenergic receptor in vivo

Eriksen, M., Ilebekk, A., Cataliotti, A., Carlson, C. R., Lyberg, T., & Aspelin, T. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0059 · Cited by 4 · see citing works

Reactive hyperemia and tissue-type plasminogen activator release in hypertensive men

Dell’Omo, G., Negri, F. D., Carmassi, F., Ruocco, L. A., Mariani, M., & Pedrinelli, R. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200301000-00005 · Cited by 5 · see citing works

Treating Hypertension in Patients with Left Ventricular Dysfunction: Hitting the Fairway and Avoiding the Rough

Joffe, S., & Phillips, R. A. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0137-9 · Cited by 2 · see citing works

[The influence of tissue and plasma angiotensin converting enzyme inhibitors on haemostasis with respect to experimental and clinical investigations].

Wojewódzka‐Żeleźniakowicz, M., Stankiewicz, A., Malinowska-Zaprzałka, M., & Chabielska, E. (2005) · PubMed · Cited by 2 · see citing works

Cardiovascular Disease and Insulin Resistance

Ajjan, R., & Grant, P. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_138 · Cited by 2 · see citing works

Tailoring the management of hypertension to comorbidities

Mendoza, M. F., Kachur, S. M., & Lavie, C. J. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000860 · Cited by 1 · see citing works

Coronary release of t-PA

Österlund, B. (2002) · Cited by 1 · see citing works

Impairment of Endothelial Thromboprotective Function by Haemodynamic and Inflammatory Stress Implications for hypertensive disease

Ulfhammer, E. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction

Carrillo-Jimenez, R., Hennekens, C. H., & Lamas, G. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-351-4_14

Is Angiotensin Receptor Blockade Antithrombotic?

Lim, H. S., & Lip, G. Y. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2790-a

Pharmakotherapie des Renin-Angiotensin- Aldosteron-Systems

Allgeier, J., & Hauf, G. F. (2004) · Springer eBooks · doi:10.1007/978-3-642-18649-3_47

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS

Gilyarevskiy, S. R. (2013) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2013-9-6-664-671

QuinaprilUpdate of its Pharmacology and Therapeutic Use in Cardiovascular Disorders

Culy, C. R., & Jarvis, B. (2002)

hypertensive rats and promotes neovascularization in spontaneously Kallikrein gene delivery attenuates cardiac remodeling

Bledsoe, G., Chao, L., & Chao, J. (2016)

Antihypertensive Drugs and Their Cardioprotective and Renoprotective Roles in the Prevention and Management of Cardiovascular Disease

Kliger, C., Schwartzbard, A. Z., Fisher, E., & WEINTRAUB, H. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00011-1

Pathogenesis and preventive approach of hypercoagulopathy and microvascular thrombosis induced mortality from COVID-19

Pramanik, P. (2020) · Indian Journal of Science and Technology · doi:10.17485/ijst/v13i30.969

Blood tPA of liver origin contributes to neurovascular coupling involving brain endothelial NMDA receptorsPreprint

Yetim, M., Furon, J., de Lizarrondo, S. M., Pouettre, E., Maubert, E., Hommet, Y., Lebouvier, L., Zheng, Z., Ali, C., & Vivien, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1706689/v1

Emerging path promoting neovascularization in chronic ischemia

Eton, D. (2025) · JVS-Vascular Insights · doi:10.1016/j.jvsvi.2025.100190

Additional file 1 of Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors

Furon, J., Yetim, M., Pouettre, E., de Lizarrondo, S. M., Maubert, E., Hommet, Y., Lebouvier, L., Zheng, Z., Ali, C., & Vivien, D. (2024) · Figshare · doi:10.6084/m9.figshare.26566058

Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition

Labinjoh, C., Newby, D. E., Pellegrini, M. P., Johnston, N. R., Boon, N. A., & Webb, D. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01562-5 · Cited by 46 · see citing works

Selective Stimulation of Tissue-Type Plasminogen Activator (t-PA) In Vivo by Infusion of Bradykinin

Brown, N. J., Nadeau, J., & Vaughan, D. E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656000 · Cited by 145 · see citing works

Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin

Pretorius, M., Rosenbaum, D., Vaughan, D. E., & Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000046268.59922.a4 · Cited by 96 · see citing works

ACE inhibitor augments the release of tissue plasminogen activator induced by bradykinin in the human coronary circulation Kazuo Minai, Tetsuya Matsumoto, Hajime Horie, Naoto Ohira, Hiroyuki Takashima, Hiroshi Yokohama, Masayuki Takahashi, Masahiko Kinoshita. First Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan

(2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)97887-8

Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy

Witherow, F. N., Dawson, P., Ludlam, C. A., Fox, K. A. A., & Newby, D. E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02061-2 · Cited by 52 · see citing works